We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
-2.78%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$1.27T
AUM Growth
-$18.6B
Cap. Flow
+$47.9B
Cap. Flow %
3.77%
Top 10 Hldgs %
28.89%
Holding
4,591
New
121
Increased
3,781
Reduced
412
Closed
115

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.99B
2
AAPL icon
Apple
AAPL
+$2.23B
3
NVDA icon
NVIDIA
NVDA
+$1.92B
4
AMZN icon
Amazon
AMZN
+$1.75B
5
META icon
Meta Platforms (Facebook)
META
+$1.1B

Sector Composition

Rank Sector Weight
1 Technology 29.36%
2 Financials 14.54%
3 Healthcare 11.04%
4 Consumer Discretionary 10.44%
5 Communication Services 8.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRNS
4426
Barinthus Biotherapeutics
BRNS
$22.8M
$11.5K ﹤0.01%
11,568
ISPC icon
4427
iSpecimen
ISPC
$2.72M
$11.4K ﹤0.01%
+268
New +$20.4K
DTCK
4428
DELISTED
Davis Commodities
DTCK
$10.7K ﹤0.01%
599
VINC
4429
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$10.2K ﹤0.01%
19,285
+7,209
+60% +$11.9K
ENLV icon
4430
Enlivex Ltd
ENLV
$35.2M
$10.1K ﹤0.01%
695
HOLO icon
4431
MicroCloud Hologram
HOLO
$33.9M
$10K ﹤0.01%
304
-4
-1% -$240
ABLV icon
4432
Able View Global
ABLV
$41M
$9.92K ﹤0.01%
10,224
QCLS
4433
Q/C Technologies Inc
QCLS
$20.5M
$9.82K ﹤0.01%
281
+115
+69% +$7.94K
TRIB
4434
Trinity Biotech
TRIB
$7.83M
$9.48K ﹤0.01%
555
-34
-6% -$805
IMG
4435
DELISTED
CIMG Inc
IMG
$9.42K ﹤0.01%
+878
New +$11.1K
HTCR icon
4436
HeartCore Enterprises
HTCR
$3.3M
$9.12K ﹤0.01%
608
OCEA
4437
DELISTED
Ocean Biomedical, Inc. Common Stock
OCEA
$8.73K ﹤0.01%
161,571
-13,737
-8% -$3.28K
DCOY
4438
Decoy Therapeutics
DCOY
$2.19M
$8.67K ﹤0.01%
+64
New +$18.6K
WORX
4439
DELISTED
SCWORX CORP NEW
WORX
$8.42K ﹤0.01%
+825
New +$15.6K
HIT
4440
Health In Tech Inc
HIT
$72.7M
$7.89K ﹤0.01%
+11,919
New +$57.4K
AERT
4441
Aeries Technology
AERT
$35.2M
$7.87K ﹤0.01%
1,609
CAPT
4442
DELISTED
Captivision
CAPT
$7.76K ﹤0.01%
16,349
IPST
4443
IP Strategy Holdings
IPST
$1.56M
$7.72K ﹤0.01%
+38
New +$15.4K
MLEC icon
4444
Moolec Science
MLEC
$4.88M
$7.64K ﹤0.01%
91
PTPI
4445
DELISTED
Petros Pharmaceuticals
PTPI
$7.47K ﹤0.01%
4,327
+2,880
+199% +$14.7K
SLGL icon
4446
Sol-Gel Technologies
SLGL
$269M
$7.24K ﹤0.01%
1,341
GTI
4447
DELISTED
Graphjet Technology
GTI
$6.93K ﹤0.01%
1,152
-173
-13% -$2.94K
GMEX
4448
GMEX Robotics
GMEX
$1.18M
$6.73K ﹤0.01%
1
-1
-50% -$34.3K
RVSN icon
4449
Rail Vision
RVSN
$8.79M
$6.64K ﹤0.01%
512
HOVR icon
4450
New Horizon Aircraft
HOVR
$115M
$6.28K ﹤0.01%
12,029

Similar funds

Geode Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Geode Capital Management held 4,591 positions worth $1.27T, down 1.4% from $1.29T the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Geode Capital Management deployed $47.9B of net new capital in Q1 2025, opening 121 new positions and adding to 3,781 existing holdings. Its largest new stake was Sandisk: 1,936,245 shares worth $92.2M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Merck, an estimated $142M trimmed.

  • Geode Capital Management's largest Q1 2025 buy was Sandisk: 1,936,245 shares worth $92.2M.
  • Geode Capital Management added most to Microsoft in Q1 2025, an estimated $2.99B increase.
  • Geode Capital Management's biggest Q1 2025 reduction was Merck, cutting an estimated $142M.
  • Geode Capital Management fully exited Altair Engineering Inc in Q1 2025, selling an estimated $152M.
  • Geode Capital Management's ten largest holdings make up 29% of its $1.27T portfolio in Q1 2025.
  • Geode Capital Management opened 121 new positions and closed 115 in Q1 2025.
  • Geode Capital Management's portfolio value fell 1.4% quarter-over-quarter to $1.27T.

Based on Geode Capital Management's 13F filing for Q1 2025, filed 13 May 2025.